The human anti-IL-1β monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis
Arthritis Research & Therapy2008Vol. 10(3), pp. R67–R67
Citations Over TimeTop 10% of 2008 papers
Rieke Alten, Hermann Gram, Leo A. B. Joosten, Wim B. van den Berg, Joachim Sieper, S Wassenberg, Gerd Burmester, Piet L. C. M. van Riel, Maria Diaz-Lorente, Gerardus Bruin, Thasia Woodworth, Christiane Rordorf, Yannik Batard, A. Wright, Thomas Jung
Abstract
ClinicalTrials.gov identifier NCT00619905.
Related Papers
- → Drug tolerability: How much ambiguity can be tolerated? A systematic review of the assessment of tolerability in clinical studies(2021)45 cited
- → Safety and Tolerability of Gabapentin as Adjunctive Therapy in a Large, Multicenter Study(1999)81 cited
- → Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study(2022)4 cited
- Tolerability of topical antimicrobials in treatment of acne vulgaris.(2014)
- → TOPICAL MEDICINES IN THE TREATMENT OF ALLERGODERMATHOSIS(2017)